Samsung Biologics logo

Samsung Biologics Employee Directory

Pharmaceutical Manufacturing인천광역시, South Korea1001-5000 Employees

Samsung Biologics is a pharmaceutical manufacturing company that operates as a fully integrated contract development and manufacturing organization (CDMO), providing development and manufacturing services for biologics. The company highlights proven regulatory approvals and the largest capacity with the fastest throughput, positioning it as a partner of choice to support biologics development and manufacturing across all stages. Its operations are located in Songdo, Incheon, South Korea, with significant expansion activity in the United States, including facilities in Rockville and Gaithersburg, Maryland, and a Maryland-based facility acquired from GSK in 2025. The organization’s scale includes 784,000 liters of bioreactor capacity in Songdo, composed largely of 15,000-liter tanks, reflecting its large-scale stainless steel manufacturing capability. The company has grown its footprint through multiple acquisitions and facility expansions in 2025 and 2026, reinforcing its global supply network for biopharmaceutical production.

Find Samsung Biologics employees' phone numbers or email addresses

Samsung Biologics Global Highlights

Location
Employees

North America
158

Minus sign iconPlus sign icon
  • United States Of America
    151
  • Canada
    7

Asia
19

Minus sign iconPlus sign icon
  • India
    3
  • Singapore
    3
  • Japan
    3
  • United Arab Emirates
    2
  • Philippines
    2
  • Pakistan
    2
  • Indonesia
    2
  • Qatar
    1
  • China
    1

Europe
10

Minus sign iconPlus sign icon
  • United Kingdom Of Great Britain And Northern Ireland
    4
  • Spain
    2
  • Ireland
    1
  • Switzerland
    1
  • Denmark
    1
  • France
    1

Africa
5

Minus sign iconPlus sign icon
  • Sudan
    1
  • Ethiopia
    1
  • Senegal
    1
  • Cameroon
    1
  • Ghana
    1

South America
4

Minus sign iconPlus sign icon
  • Brazil
    2
  • Peru
    1
  • Argentina
    1

Samsung Biologics's Leadership

  • Cdo Cell Line Development at Samsung Biologics
    W. C.
    Cdo Cell Line Development
  • Cdo R & D, Scientist at Samsung Biologics
    Y. C.
    Cdo R & D, Scientist
  • Vice President Of Manufacturing Science And Technology at Samsung Biologics
    B. T. C.
    Vice President Of Manufacturing Science And Technology
  • Head Of Advanced Process Development at Samsung Biologics
    A. T.
    Head Of Advanced Process Development
  • Head Of Oncology R&d at Samsung Biologics
    W. Z.
    Head Of Oncology R&d
  • Head Of Msat Department Vice President at Samsung Biologics
    Y. Y. J.
    Head Of Msat Department Vice President
  • Head Of Marketing at Samsung Biologics
    M. W.
    Head Of Marketing
  • Board Chair & Ceo at Samsung Biologics
    J. R.
    Board Chair & Ceo

Samsung Biologics Employee Metrics

100%
50%
0%
2026
2025
  • Research
  • Engineering
  • Quality Assurance
  • Program & Project Management
  • Human Resources
  • Other
  • Biotechnology
  • Sales
  • Legal
  • Administrative

Contact profiles from Samsung Biologics

Name
Title
Contact
Location
Last Update
  • Vp, Head Of Cdo Antibody Department at Samsung Biologics
    J. K.
    Vp, Head Of Cdo Antibody Department
    South Korea
    Apr 15, 2026
  • Cdo R & D, Scientist at Samsung Biologics
    Y. C.
    Cdo R & D, Scientist
    South Korea
    Sep 12, 2026
  • Lead Of Cdo Cell Culture Development Team at Samsung Biologics
    T. L.
    Lead Of Cdo Cell Culture Development Team
    South Korea
    Jul 23, 2025
  • Excom Member, Executive Vice President - Head Of Operations at Samsung Biologics
    P. C.
    Excom Member, Executive Vice President - Head Of Operations
    South Korea, Seoul
    Sep 16, 2026
  • Senior Director, Head Of Marketing Communications at Samsung Biologics
    C. K.
    Senior Director, Head Of Marketing Communications
    South Korea, Incheon
    Sep 23, 2026
  • Executive Vice President at Samsung Biologics
    B. H. M.
    Executive Vice President
    South Korea
    Sep 09, 2026
  • Head Of Advanced Process Development at Samsung Biologics
    A. T.
    Head Of Advanced Process Development
    South Korea
    Sep 08, 2026
  • Vice President Of Manufacturing Science And Technology at Samsung Biologics
    B. T. C.
    Vice President Of Manufacturing Science And Technology
    Oct 14, 2026
  • Senior Vice President at Samsung Biologics
    D. J. K.
    Senior Vice President
    Sep 06, 2026
  • Executive Vice President R&d Head at Samsung Biologics
    J. 정. J.
    Executive Vice President R&d Head
    South Korea, Seoul
    Oct 07, 2026

Frequently Asked Questions

What is Samsung Biologics known for?

Minus sign iconPlus sign icon
Samsung Biologics was founded in 2011 and operates in the Pharmaceutical Manufacturing industry. Explore Samsung Biologics's company overview page for more information.

What is Samsung Biologics's most common email format?

Minus sign iconPlus sign icon
Samsung Biologics employees' email format typically follows the pattern of First.Last@samsung.com. Trying to find reliable and up-to-date employee contact data? Find more Samsung Biologics email formats with LeadIQ.

How many employees does Samsung Biologics have currently?

Minus sign iconPlus sign icon
Samsung Biologics has approximately 2.6K employees as of October 2026. These team members are located across 5 continents, including North America, Asia and Europe.

Who are Samsung Biologics's key employees and leadership?

Minus sign iconPlus sign icon

As of October 2026, Samsung Biologics's key employees include:

  • Cdo Cell Line Development: W. C.
  • Cdo R & D, Scientist: Y. C.
  • Vice President Of Manufacturing Science And Technology: B. T. C.
  • Head Of Advanced Process Development: A. T.
  • Head Of Oncology R&d: W. Z.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.